Kenneth Hoberman - 28 Sep 2023 Form 4 Insider Report for TG THERAPEUTICS, INC. (TGTX)

Role
Director
Signature
/s/ Kenneth Hoberman
Issuer symbol
TGTX
Transactions as of
28 Sep 2023
Net transactions value
$0
Form type
4
Filing time
29 Sep 2023, 18:01:00 UTC
Previous filing
20 Jun 2023
Next filing
13 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TGTX Common Stock Award $0 +20,000 +9% $0.000000 242,685 28 Sep 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a grant of restricted shares that will vest on June 14, 2024.
F2 Includes shares of restricted Common Stock, which vest over various time periods.